SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-19-002133
Filing Date
2019-05-13
Accepted
2019-05-13 07:01:12
Documents
10
Period of Report
2019-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5946
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 241278
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 223257
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 5737
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 5751
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 21339
7 GRAPHIC exhibit99-5x001.jpg GRAPHIC 8940
8 GRAPHIC exhibit99-2x5x1.jpg GRAPHIC 23761
9 GRAPHIC exhibit99-2x6x1.jpg GRAPHIC 33606
10 GRAPHIC trilogo.jpg GRAPHIC 6353
  Complete submission text file 0001062993-19-002133.txt   604930
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 19816874
SIC: 2834 Pharmaceutical Preparations